{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T01:00:15Z","timestamp":1709427615957},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Clinical Pathology"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1309\/0tdg-8bec-lwcb-xcdk","type":"journal-article","created":{"date-parts":[[2005,12,29]],"date-time":"2005-12-29T11:54:33Z","timestamp":1135857273000},"page":"290-295","source":"Crossref","is-referenced-by-count":1,"title":["Modified Plasma-Based Ecarin Clotting Time Assay for Monitoring of Recombinant Hirudin During Cardiac Surgery"],"prefix":"10.1093","volume":"125","author":[{"given":"Tak-Shun","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"Greilich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"E00001","unstructured":"Lindhoff-Last E, Piechottka GP, Rabe F, et al. Hirudin determination in plasma can be strongly influenced by the prothrombin level. Thromb Res. 2000;100:55-60."},{"key":"E00002","unstructured":"Hafner G, Fickenscher K, Friesen HJ, et al. Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma. Thromb Res. 1996;77:165-173."},{"key":"E00003","unstructured":"Nowak G, Bucha E. A new method for the therapeutical monitoring of hirudin [abstract]. Thromb Haemost. 1993;69:1306."},{"key":"E00004","unstructured":"Nowak G, Bucha E. Quantitative determination of hirudin in blood and body fluids. Semin Thromb Hemost. 1996;22:197-202."},{"key":"E00005","unstructured":"Potzsch B, Hund S, Madlener K, et al. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay. Thromb Res. 1997;86:373-383."},{"key":"E00006","unstructured":"Nishida S, Fujita T, Kohno N, et al. cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom. Biochemistry. 1995;34:1771-1778."},{"key":"E00007","unstructured":"Boskovic DS, Giles AR, Nesheim ME. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid. J Biol Chem. 1990;265:10497-10505."},{"key":"E00008","unstructured":"Novoa E, Seegers WH. Mechanisms of alpha-thrombin and beta-thrombin-E formation: use of ecarin for isolation of meizothrombin 1. Thromb Res. 1980;18:657-668."},{"key":"E00009","unstructured":"Peace GS. Taguchi Methods: A Hands-on Approach to Quality Engineering. Reading, MA: Addison-Wesley; 1993."},{"key":"E00010","unstructured":"Clauss A. Gerinnungs-physiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol. 1957;17:237-246."},{"key":"E00011","unstructured":"Zeymer U, Neuhaus KL. Hirudin and excess bleeding: implications for future use. Drug Saf. 1995;12:234-239."},{"key":"E00012","unstructured":"Walenga JM, Hoppensteadt D, Koza M, et al. Laboratory assays for the evaluation of recombinant hirudin. Haemostasis. 1991;21:49-63."},{"key":"E00013","unstructured":"Nowak G. Monitoring of the action of antithrombin agents by ecarin clotting time. In: Pifarre R, ed. New Anticoagulants for the Cardiovascular Patient. Philadelphia, PA: Hanley & Belfus; 1997:539-550."},{"key":"E00014","unstructured":"Poetzsch B, Madlener K. Management of cardiopulmonary bypass anticoagulation in patients with heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia. New York, NY: Marcel Dekker; 2000:355-369."},{"key":"E00015","unstructured":"Van den Bos AA, Deckers JW, Heyndrickx GR, et al. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation. 1993;88(5 pt 1):2058-2066."},{"key":"E00016","unstructured":"Zolhelyi P, Webster MWI, Fuster V, et al. Recombinant hirudin in patients with chronic, stable coronary artery disease: safety, half-life, and effect on coagulation parameters. Circulation. 1993;88:2015-2022."},{"key":"E00017","unstructured":"Antman EM. Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial. Circulation. 1994;90:1624-1630."},{"key":"E00018","unstructured":"The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIA Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation. 1994;90:1631-1637."},{"key":"E00019","unstructured":"OASIS-2-Investigators. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularization procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Lancet. 1999;353:429-438."},{"key":"E00020","unstructured":"Schiele F, Lindgaerde F, Eriksson H, et al, for the International Multicentre Hirudin Study Group. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose ranging randomized trial. Thromb Haemost. 1997;77:834-838."},{"key":"E00021","unstructured":"Reiss F-C, Lower C, Seelig C, et al. Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: successful for aortic valve replacement in man. J Thorac Cardiovasc Surg. 1995;110:265-267."},{"key":"E00022","unstructured":"Potzsch B, Grweinacher A, Reiss F-C, et al. Recombinant hirudin as anticoagulant in cardiac surgery: experiences with eleven patients [abstract]. Ann Hematol. 1996;72:A4."},{"key":"E00023","unstructured":"Reiss F-C, Potzsch B, Bader R, et al. A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery. Eur J Cardiothorac Surg. 1996;10:386-388."},{"key":"E00024","unstructured":"Greinacher A, Volpel H, Janssens U, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia. Circulation. 1999;99:73-80."},{"key":"E00025","unstructured":"Koza MJ, Walenga JM, Fareed J, et al. A new approach in monitoring recombinant hirudin during cardiopulmonary bypass. Semin Thromb Hemost. 1993;19:90-96."},{"key":"E00026","unstructured":"Verstraete M, Nurmohamed M, Kienast J, et al, for the European Hirudin in Thrombosis Group. Biological effects of recombinant hirudin (CGP 39393) in human volunteers. J Am Coll Cardiol. 1993;22:1080-1088."},{"key":"E00027","unstructured":"Terrell MR, Walenga JM, Koza MJ, et al. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass model. Ann Thorac Surg. 1996;62:506-511."},{"key":"E00028","unstructured":"Marbet GA, Verstraete M, Kienast J, et al. Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers. J Cardiovasc Pharmacol. 1993;22:364-372."},{"key":"E00029","unstructured":"Nurmohamed MT, Berckmans RJ, Morrien-Salomons WM, et al. Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. Thromb Haemost. 1994;72:685-692."},{"key":"E00030","unstructured":"Walenga JM, Bakhos M, Messmore HL, et al. Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model. Blood Coagul Fibrinolysis. 1991;2:105-111."},{"key":"E00031","unstructured":"Spannagl M, Bichler H, Lill H, et al. A fast photometric assay for the determination of hirudin. Haemostasis. 1991;21:36-40."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"deposited":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T10:10:23Z","timestamp":1447927823000},"score":1,"resource":{"primary":{"URL":"http:\/\/ajcp.metapress.com\/openurl.asp?genre=article&id=doi:10.1309\/0TDG-8BEC-LWCB-XCDK"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["0TDG8BECLWCBXCDK"],"URL":"https:\/\/doi.org\/10.1309\/0tdg-8bec-lwcb-xcdk","relation":{},"ISSN":["0002-9173"],"issn-type":[{"value":"0002-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}